Breast fibroadenoma in a male-to-female transsexual patient after hormonal treatment

European Journal of Surgery, Supplement

Volumn 168, Issue 588, 2003, Pages 69-71

  Lemmo, GianFranco ^a   Garcea, Nicola ^a   Corsello, Salvatore ^a   Tarquini, Elisabetta ^a   Palladino, Tiziana ^b   Ardito, Guglielmo ^a   Garcea, Riccardo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b Catholic University ^*

Author keywords

Biphasic tumors; Breast neoplasms; Case report; Cyproterone acetate adverse effects; Ethinyl estradiol adverse effects; Fibroadenoma; Human male orchiectomy transsexual; Male chemically induced; Male pathology breast neoplasms

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CYPROTERONE ACETATE; DIGOXIN; ESTROGEN; ETHINYLESTRADIOL; HEPARIN; NITRATE; QUINIDINE; SPIRONOLACTONE; STEROID; ANTIANDROGEN;

ADULT; ARTICLE; BREAST AUGMENTATION; BREAST FIBROADENOMA; BREAST HYPERPLASIA; CASE REPORT; ECHOMAMMOGRAPHY; GYNECOMASTIA; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; INCIDENCE; MALE; MAMMOGRAPHY; PRIORITY JOURNAL; SEX TRANSFORMATION; SURGICAL TECHNIQUE; TRANSSEXUALISM; BREAST TUMOR; FIBROADENOMA; PATHOLOGY;

ADULT; ANDROGEN ANTAGONISTS; BREAST NEOPLASMS, MALE; CYPROTERONE ACETATE; ETHINYL ESTRADIOL; FIBROADENOMA; HUMANS; MALE; TRANSSEXUALISM;

EID: 0043166714     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ansah-Boateng Y, Tavassoli FA. Fibroadenoma and cystosarcoma phylloides of the male breast. Mod Pathol 1992; 5: 114-116.
2. Bartoli C, Zurrida SM, Clemente C. Phylloides tumor in a male patient with bilateral gynaecomastia induced by estrogen therapy for prostatic carcinoma. Eur J Surg Oncol 1991; 17: 215-217.
3. Greenberg R, Skornick Y, Kaplan O. Management of breast fibroadenomas. J Gen Intern Med 1998; 13: 640-645.
4. Holleb AI, Freeman HP, Farrow JH. Cancer of the male breast, part II. NY State J Med 1968; 68: 656-663.
5. Kanhai RC, Hage JJ, Bloemena E, van Diest PJ, Karim RB. Mammary fibroadenoma in a male-to-female transsexual. Histopathology 1999; 35: 183-185.
6. Kanhai RC, Hage JJ, van Diest PJ, Bloemena E, Mulder JW. Short-term and long term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transexuals in comparison with two chemically castrated men. Am J Surg Pathol 2000; 24: 74-80.
7. Mizukami Y, Nonomura A, Yamada T et al. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues. Anticancer Res 1990; 10: 1115-1126.
8. Nielsen BB. Fibroadenomatoid hyperplasia of the male breast. Am J Surg Pathol 1990; 14: 774-777.
9. Pilichowska M, Kimura N, Fujiwara H, Nagura H. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma. Mod Pathol 1997; 10: 969-975.
10. Rosen PP. Benign proliferative lesions of the male breast. In: Rosen PP, ed. Rosen's breast pathology. Philadelphia: Lippincott-Raven, 1997; 609-617.
11. Scala S, Saeki T, Lynch A, Salomon D, Merino MJ, Bates SE. Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues. Diagn Mol Pathol 1995; 4: 136-142.
12. Uchida T, Ishii M, Motomiya Y. Fibroadenoma associated with gynaecomastia in an adult man-case report. Scand J Plast Reconstr Surg Hand Surg 1993; 27: 327-329.
13. Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumor: comparison with fibroadenoma. Virchows Arch 1998; 433: 311-314.